Proteina Co Ltd
KOSDAQ:468530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Proteina Co Ltd
KOSDAQ:468530
|
KR |
|
Fidia SpA
MIL:FDA
|
IT |
|
A
|
Anima Holding SpA
F:124
|
IT |
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
KR |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Proteina Co Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Proteina Does
PROTEINA Co., Ltd. engages in the provision of deoxyribonucleic acid based diagnostics through its protein to protein interaction profiling technology. The company is headquartered in Seoul, Seoul and currently employs 53 full-time employees. The company went IPO on 2025-07-29. The firm is mainly engaged in the provision and sale of next generation PPI biomarker development solutions, antibody design and big data generation solutions, as well as single molecule protein interaction detection (SPID) platform systems’ equipment and consumables.
- Headquarters
- Korea KR
- Employees
- 53
- IPO date
- Jul 29, 2025